Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients

for
Breast Cancer, Ductal Carcinoma In Situ
Location: Philadelphia PA
Sponsor: Thomas Jefferson University

Sex: Female

Age: 18+

Code: NCT07478016

Recruiting

Family Building Decision Support for Female Adolescent and Young Adult Cancer Survivors

for
Cancer Survivorship, Family Planning,
Location: Durham NC
Sponsor: Duke University

Sex: Female

Age: 18 - 39

Code: NCT07471685

Recruiting

Cycling-Based Aerobic Exercise Intervention for Individuals With Chemotherapy-Induced Peripheral Neuropathy (CIPN)

for
Cancer, Adults
Location: Edmonton
Sponsor: University of Alberta

Sex: All

Age: 18+

Code: NCT07150117

Recruiting

A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.

for
TP53 Y220C Mutation, Advanced Solid Tumors
Location: Orlando FL, Nashville TN, Dallas TX, San Antonio TX,
Sponsor: PMV Pharmaceuticals, Inc

Sex: All

Age: 18+

Code: NCT07372625

Phase 1, Recruiting

Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer

for
Breast Cancer, Metastatic Breast Cancer,
Location: Orange CA
Sponsor: University of California, Irvine

Sex: All

Age: 18+

Code: NCT05524584

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Pelvic Health Rehabilitation After Breast and Gynecologic Cancer

for
Gynecologic Cancers, Breast Cancer Female, Incontinence,
Location: Quebec, Edmonton
Sponsor: Laval University

Sex: Female

Age: 18+

Code: NCT06822582

Recruiting

SB-4826 in Adult Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphomas

for
Non Hodgkin Lymphoma, Solid Tumor
Location: La Jolla CA
Sponsor: University of California, San Diego

Sex: All

Age: 18+

Code: NCT07222631

Phase 1, Phase 2, Recruiting

Phase 1 Study of JV-394 Autologous Anti-CD94 CAR T for r/r CD94+ T/NK Cell Neoplasms

for
Neoplasms
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07382817

Phase 1, Recruiting

Artificial Intelligence and Machine Learning to Guide CDK4/6 Inhibitor Rechallenge in Breast Cancer.

for
Breast Cancer
Location: La Jolla CA
Sponsor: University of California, San Diego

Sex: All

Age: 18+

Code: NCT07227233

Phase 2, Recruiting

A Study of GEN1106 in Participants With Solid Tumors

for
Solid Tumors, Urothelial Carcinoma
Location: New Haven CT, Lake Success NY, Myrtle Beach SC,
Sponsor: Genmab

Sex: All

Age: 18+

Code: NCT07416123

Phase 1, Recruiting

Feasibility and Acceptability of Internet-based Parent-child Interaction Therapy (I-PCIT) in Pediatric Cancer

for
Pediatric Cancer, Oncology, Disruptive Behavior
Location: St. Petersburg FL
Sponsor: Johns Hopkins All Children's Hospital

Sex: All

Age: 0+

Code: NCT06346782

Recruiting

Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors

for
Solid Tumors, Sarcomas
Location: New Haven CT, Long Island City NY, New York NY,
Sponsor: Zai Lab (Shanghai) Co., Ltd.

Sex: All

Age: 18+

Code: NCT07374848

Phase 1, Recruiting

Role of TXA in Patients Undergoing Breast Free Flap Reconstruction

for
Breast Cancer, Blood Loss, Surgical
Location: Charlottesville VA
Sponsor: University of Virginia

Sex: Female

Age: 18+

Code: NCT06428682

Recruiting

Visual Communication: Digital Tool to Improve the Understanding of Treatment Options for Patients With Cancer and Increase Satisfaction of the Overall Experience for Patients, Caregivers, and Providers

for
Cancer
Location: New York NY
Sponsor: NYU Langone Health

Sex: All

Age: 18 - 70+

Code: NCT06927050

Recruiting

Remote Digital Physiologic Data Collection in Cancer: An MSK Registry Protocol

for
Solid Tumor
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT05390827

Recruiting

A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change

for
Metastatic Cancer
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT05010031

Phase 2, Recruiting

A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

for
Neoplasms, Colorectal, Neoplasms
Location: Toronto, Montreal, Hamilton, Canton OH, Detroit MI,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07213609

Phase 1, Phase 2, Recruiting

Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence

for
Solid Tumor
Location: Orange CA, Long Beach CA
Sponsor: Miller Children's & Women's Hospital Long Beach

Sex: All

Age: 1 - 31

Code: NCT02446431

Early Phase 1, Recruiting

Utero-ovarian Transposition in Patients With Pelvic Malignancies Undergoing Whole Pelvic Radiotherapy

for
Colorectal (Colon or Rectal) Cancer, Pelvic Malignancies,
Location: Tampa FL
Sponsor: University of South Florida

Sex: Female

Age: 1 - 3

Code: NCT07419490

Recruiting

KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer

for
Gastric Cancer, Breast Cancer, Cervical Cancer, Lung Cancer
Location: New Brunswick NJ
Sponsor: Christian Hinrichs

Sex: All

Age: 18+

Code: NCT05483491

Phase 1, Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial